E
Elizabeth R. Zell
Researcher at Centers for Disease Control and Prevention
Publications - 135
Citations - 21416
Elizabeth R. Zell is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Population & Vaccination. The author has an hindex of 55, co-authored 135 publications receiving 19844 citations. Previous affiliations of Elizabeth R. Zell include National Center for Immunization and Respiratory Diseases & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Invasive Methicillin-Resistant Staphylococcus aureus Infections in the United States
R. Monina Klevens,Melissa Morrison,Joelle Nadle,Ken Gershman,Lee H. Harrison,Ruth Lynfield,Ghinwa Dumyati,John M. Townes,Allen S. Craig,Elizabeth R. Zell,Gregory E. Fosheim,Linda K. McDougal,Roberta B. Carey,Scott K. Fridkin +13 more
TL;DR: Invasive MRSA infection affects certain populations disproportionately and is a major public health problem primarily related to health care but no longer confined to intensive care units, acute care hospitals, or any health care institution.
Journal ArticleDOI
Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States.
Cynthia G. Whitney,Monica M. Farley,James L. Hadler,Lee H. Harrison,Catherine Lexau,Arthur Reingold,Lewis B. Lefkowitz,Paul R. Cieslak,Martin S. Cetron,Elizabeth R. Zell,James H. Jorgensen,Anne Schuchat +11 more
TL;DR: Because a limited number of serotypes account for most infections with drug-resistant strains, the new conjugate vaccines offer protection against most drug- resistant strains of S. pneumoniae.
Journal ArticleDOI
Effect of Introduction of the Pneumococcal Conjugate Vaccine on Drug-Resistant Streptococcus pneumoniae
Moe H. Kyaw,Ruth Lynfield,William Schaffner,Allen S. Craig,James L. Hadler,Arthur Reingold,Ann Thomas,Lee H. Harrison,Nancy M. Bennett,Monica M. Farley,Monica M. Farley,Richard R. Facklam,James H. Jorgensen,John M. Besser,Elizabeth R. Zell,Anne Schuchat,Cynthia G. Whitney +16 more
TL;DR: The rate of antibiotic-resistant invasive pneumococcal infections decreased in young children and older persons after the introduction of the conjugate vaccine, and there was an increase in infections caused by serotypes not included in the vaccine.
Journal ArticleDOI
Bacterial Meningitis in the United States, 1998-2007
Michael C. Thigpen,Cynthia G. Whitney,Nancy E. Messonnier,Elizabeth R. Zell,Ruth Lynfield,James L. Hadler,Lee H. Harrison,Monica M. Farley,Arthur Reingold,Nancy M. Bennett,Allen S. Craig,William Schaffner,Ann Thomas,Melissa Lewis,Elaine Scallan,Anne Schuchat +15 more
TL;DR: The rates of bacterial meningitis have decreased since 1998, but the disease still often results in death, and the burden of bacterialMeningitis is now borne more by older adults.
Journal ArticleDOI
Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005.
Christina R. Phares,Ruth Lynfield,Monica M. Farley,Janet C. Mohle-Boetani,Lee H. Harrison,Susan Petit,Allen S. Craig,William Schaffner,Shelley M. Zansky,Ken Gershman,Karen Stefonek,Bernadette A. Albanese,Elizabeth R. Zell,Anne Schuchat,Stephanie J. Schrag +14 more
TL;DR: In this article, an analysis of active, population-based surveillance in 10 states participating in the Active Bacterial Core surveillance/Emerging Infections Program Network was performed to describe disease trends among populations that might benefit from vaccination and among newborns during a period of evolving prevention strategies.